Primary Gastric Mantle Cell Lymphoma in a Patient with Long Standing History of Crohn's Disease

2004 ◽  
Vol 45 (7) ◽  
pp. 1459-1462 ◽  
Author(s):  
Markus Raderer ◽  
Andreas Püspök ◽  
Thomas Birkner ◽  
Berthold Streubel ◽  
Andreas Chott
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Mantle Cell ◽  
History Of

scholarly journals S1704 Mantle Cell Lymphoma Presenting as Colonic Polypoid Nodules in a Crohn’s Disease Patient With History of Azathioprine Use

2020 ◽  
Vol 115 (1) ◽  
pp. S877-S877 ◽  
Author(s):  
Anam Omer ◽  
Mohanad T. Al-Qaisi ◽  
Nael Haddad ◽  
Yasmin Alishahi
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Disease Patient ◽  
Mantle Cell ◽  
History Of

scholarly journals Mantle Cell Lymphoma Presenting as a Subcutaneous Mass of the Right Leg

2020 ◽  
Vol 13 (2) ◽  
pp. 774-782
Author(s):  
Drew A. Fajardo ◽  
Joel France ◽  
Bogna I. Targonska ◽  
H. Bobby Kahlon ◽  
Max J. Coppes
Keyword(s):  
Bone Marrow ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Bone Marrow Involvement ◽  
Non Hodgkin Lymphoma ◽  
Mantle Cell ◽  
History Of ◽  
Subcutaneous Mass ◽  
Systemic Symptoms ◽  
The Right

Mantle cell lymphoma (MCL) is a relatively rare B-cell non-Hodgkin lymphoma, typically presenting with extensive lymphadenopathy, bone marrow involvement, and splenomegaly. Extranodal sites can also be involved. We discuss a 73-year-old man whose MCL presented with a 6-month history of a subdermal mass of the right upper thigh and no systemic symptoms.

scholarly journals Mantle Cell Lymphoma of the Gastrointestinal Tract (Lymphomatous Polyposis)

1996 ◽  
Vol 10 (3) ◽  
pp. 144-148
Author(s):  
Hugh James Freeman
Keyword(s):  
Gastrointestinal Tract ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Mantle Cell ◽  
History Of ◽  
Postmortem Studies ◽  
Gastrointestinal Lymphomas ◽  
Aggressive Clinical Course ◽  
Widespread Dissemination ◽  
Entire Gastrointestinal Tract

A74-year-old male with a history of a tonsillar lymphoma developed diarrhea. Investigations led to detection of extensive intestinal lymphomatous polyposis (mantle cell lymphoma). After an aggressive clinical course with associated nodal and peripheral blood involvement, death followed within three months. Postmortem studies revealed widespread dissemination within the entire gastrointestinal tract, including the esophagus, stomach, and small and large intestines. Although this type of lymphoma is rare and accounts for only about 1% to 8% of all forms of primary B cell gastrointestinal lymphomas in North America, separation from other subtypes has become more important because of reported responses of mucosa-associated lymphoid tissue-lymphomas to antibiotics aimed atHelicobacter pylorieradication.

scholarly journals Mantle cell lymphoma: primary oral presentation

2017 ◽  
Vol 99 (1) ◽  
pp. e13-e14
Author(s):  
S Ainscough ◽  
AM Power ◽  
AN Brown
Keyword(s):  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Emission Tomography ◽  
Incisional Biopsy ◽  
Floor Of Mouth ◽  
Positron Emission ◽  
Mantle Cell ◽  
Assessment And Treatment ◽  
History Of ◽  
Marker Studies

Mantle-cell lymphoma is an uncommon lymphoid malignancy of B-cells. It is often aggressive and prognosis is poor. A 69-year-old gentleman with a history of ischaemic heart disease was referred from primary care with a painless right floor of mouth swelling that had been present for 1 month. He otherwise completely asymptomatic. Incisional biopsy of the lesion was undertaken and marker studies demonstrated mantle cell lymphoma. Positron emission tomography–computed tomography and bone marrow biopsy showed widespread but low volume involvement. The patient was referred to the haematology multidisciplinary team for further assessment and treatment.

Ataxic gait and hearing loss in a patient with a history of Mantle Cell Lymphoma

2013 ◽  
Vol 24 ◽  
pp. e161
Author(s):  
L. Adelino ◽  
A. Real ◽  
C. Lopes ◽  
I. Martins ◽  
C. Gonçalves
Keyword(s):  
Hearing Loss ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Ataxic Gait ◽  
Mantle Cell ◽  
History Of

scholarly journals Recurrent Mantle Cell Lymphoma Presenting as Gastrointestinal Bleeding

2018 ◽  
Vol 12 (2) ◽  
pp. 379-384 ◽  
Author(s):  
Rafeeq Ahmed ◽  
Kishore Kumar ◽  
Jasbir Makker ◽  
Masooma Niazi ◽  
Bhavna Balar
Keyword(s):  
Abdominal Pain ◽  
Gastrointestinal Tract ◽  
Gastrointestinal Bleeding ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Duodenal Bulb ◽  
Colon Polyps ◽  
Ascending Colon ◽  
Mantle Cell ◽  
History Of

Mantle cell lymphoma is a rare and aggressive subtype of B-cell non-Hodgkin lymphomas. Mantle cell lymphoma frequently involves extranodal sites, and gastrointestinal tract is involved microscopically and macroscopically in more than 80% of cases. We present two cases of recurrent mantle cell lymphoma presenting with lower and upper gastrointestinal bleeding, respectively. A 58-year-old woman with a history of recurrent mantle cell lymphoma treated with chemotherapy and stem cell transplantation presented with left-sided abdominal pain and hematochezia. Colonoscopy showed a mass-like lesion in the ascending colon, polyps in the ascending colon, and splenic flexure. A 68-year-old man with a history of mantle cell lymphoma treated with chemotherapy presented with epigastric pain and melena. Esophagogastroduodenoscopy showed a large polypoidal ulcerated mass with oozing in the duodenal bulb. Biopsies in both patients were suggestive of mantle cell lymphoma. Patients with mantle cell lymphoma could be asymptomatic or may present with abdominal pain, obstruction, diarrhea, or gastrointestinal bleeding. In patients presenting with gastrointestinal symptoms, endoscopy must be pursued and biopsies must be taken for any suspicious lesions as well as normal mucosa to exclude mantle cell lymphoma as an etiology for the lesion or symptoms. Even though there are no standard guidelines for endoscopic screening of gastrointestinal tract in asymptomatic patients, one should be aware of involvement of gastrointestinal tract in the early course of disease or recurrent disease. Although mantle cell lymphoma is initially responsive to chemotherapy, it eventually becomes refractory with a median survival of 3–5 years.

scholarly journals Metastatic Mantle Cell Lymphoma to the Pituitary Gland: Case Report and Literature Review

2016 ◽  
Vol 9 (1) ◽  
pp. 25-32 ◽  
Author(s):  
Arthur Wang ◽  
Nathan Carberry ◽  
Elena Solli ◽  
George Kleinman ◽  
Adesh Tandon
Keyword(s):  
Pituitary Gland ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Sella Turcica ◽  
Pituitary Tumors ◽  
Surgical Excision ◽  
Gastrointestinal Carcinoma ◽  
Metastatic Lesions ◽  
Mantle Cell ◽  
History Of

We present an unusual case of a metastatic mantle cell lymphoma (MCL) to the pituitary gland. The patient had a known history of MCL for which she previously received chemotherapy. She presented with new-onset diplopia and confusion, and reported a history of progressive vision blurriness associated with headache, nausea, and vomiting. MRI of the brain showed an enhancing lesion within the sella turcica involving the cavernous sinuses bilaterally, extending into Meckel's cave on the left, and abutting the optic nerves bilaterally. Following surgical excision, histopathology revealed the tumor to be a MCL. Metastatic pituitary tumors are rare and have been estimated to make up 1% of tumors discovered in the sellar region. The two most common secondary metastatic lesions to the sella are breast and lung carcinoma followed by prostate, renal cell, and gastrointestinal carcinoma. Metastatic lymphoma to the pituitary gland is especially rare and is estimated to constitute 0.5% of all metastatic tumors to the sella turcica. To our knowledge, this is the first reported case of MCL metastasizing to the pituitary gland.

scholarly journals Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma

2015 ◽  
Vol 185 (6) ◽  
pp. 1740-1748 ◽  
Author(s):  
Aliki Xochelli ◽  
Lesley-Ann Sutton ◽  
Andreas Agathangelidis ◽  
Evangelia Stalika ◽  
Maria Karypidou ◽  
...  
Keyword(s):  
Natural History ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Molecular Evidence ◽  
Mantle Cell ◽  
History Of

scholarly journals Aberrant Expression of CD19 and CD43 in a Patient With Therapy-Related Acute Myeloid Leukemia and a History of Mantle Cell Lymphoma

2009 ◽  
Vol 25 (7) ◽  
pp. 389-394 ◽  
Author(s):  
Yen-Chuan Hsieh ◽  
Chien-Liang Lin ◽  
Chao-Jung Tsao ◽  
Pin-Pen Hsieh ◽  
Ching-Cherng Tzeng ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Mantle Cell Lymphoma ◽  
Myeloid Leukemia ◽  
Cell Lymphoma ◽  
Aberrant Expression ◽  
Mantle Cell ◽  
History Of ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document